Tina Meißgeier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tina Meißgeier has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anja-Katrin Bosserhoff
Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg
2 shared publications - Ata Jadid Ahari
School of Computation, Information and Technology Technical University of Munich Garching Germany
2 shared publications - Christian Mertes
School of Computation, Information and Technology, Technical University of Munich, Garching, Germany
2 shared publications - Julien Gagneur
TUM School of Computation, Information and Technology, Technical University of Munich, Garching, Germany
2 shared publications - Lisa Linck-Paulus
Institute of Biochemistry Friedrich‐Alexander‐University Erlangen‐Nürnberg (FAU) Erlangen Germany
2 shared publications - Melanie Kappelmann-Fenzl
Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
2 shared publications
Latest Publications
- Open Access
- 19 February 2025
- Published by Wiley in Cell Proliferation
- Vol. 58 (2)
Featured Cover
The cover image is based on the article Splicing control by PHF5A is crucial for melanoma cell survival by Anja Katrin Bosserhoff et al., https://doi.org/10.1111/cpr.13741. image
- 19 February 2025
- Published by Wiley in Cell Proliferation
- Vol. 58 (2)
Open AccessFeatured Cover
The cover image is based on the article Splicing control by PHF5A is crucial for melanoma cell survival by Anja Katrin Bosserhoff et al., https://doi.org/10.1111/cpr.13741. image
- Open Access
- 30 August 2024
- Published by Wiley in Cell Proliferation
- Vol. 58 (2) , e13741
Splicing control by PHF5A is crucial for melanoma cell survival
Abnormalities in alternative splicing are a hallmark of cancer formation. In this study, we investigated the role of the splicing factor PHD finger protein 5A (PHF5A) in melanoma. Malignant melanoma is the deadliest form of skin cancer, and patients with a high PHF5A expression show poor overall survival. Our data revealed that an siRNA‐mediated downregulation of PHF5A in different melanoma cell lines leads to massive splicing defects of different tumour‐relevant genes. The loss of PHF5A results in an increased rate of apoptosis by triggering Fas‐ and unfolded protein response (UPR)‐mediated apoptosis pathways in melanoma cells. These findings are tumour‐specific because we did not observe this regulation in fibroblasts. Our study identifies a crucial role of PHF5A as driver for melanoma malignancy and the described underlying splicing network provides an interesting basis for the development of new therapeutic targets for this aggressive form of skin cancer.
- 30 August 2024
- Published by Wiley in Cell Proliferation
- Vol. 58 (2) , e13741
Open AccessSplicing control by PHF5A is crucial for melanoma cell survival
Abnormalities in alternative splicing are a hallmark of cancer formation. In this study, we investigated the role of the splicing factor PHD finger protein 5A (PHF5A) in melanoma. Malignant melanoma is the deadliest form of skin cancer, and patients with a high PHF5A expression show poor overall survival. Our data revealed that an siRNA‐mediated downregulation of PHF5A in different melanoma cell lines leads to massive splicing defects of different tumour‐relevant genes. The loss of PHF5A results in an increased rate of apoptosis by triggering Fas‐ and unfolded protein response (UPR)‐mediated apoptosis pathways in melanoma cells. These findings are tumour‐specific because we did not observe this regulation in fibroblasts. Our study identifies a crucial role of PHF5A as driver for melanoma malignancy and the described underlying splicing network provides an interesting basis for the development of new therapeutic targets for this aggressive form of skin cancer.